News

Agfa HealthCare has signed a contract with the National Heart Centre (NHC) of Singapore, the national referral centre ...

Home December 06, 2006
Home
News

The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...

Home December 06, 2006
Home
News

Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...

Home December 06, 2006
Home
News

Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...

Home December 06, 2006
Home
News

The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...

Home December 05, 2006
Home
News

The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...

Home December 05, 2006
Home
News

The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...

Home December 05, 2006
Home
News

The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...

Home December 04, 2006
Home
Feature | Judy Harvey

Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...

Home December 04, 2006
Home
News

Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...

Home December 04, 2006
Home
News

Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...

Home December 04, 2006
Home
Case Study

One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...

Home December 04, 2006
Home
News

CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...

Home December 04, 2006
Home
News

Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.

Home December 03, 2006
Home
News

Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...

Home December 03, 2006
Home
Subscribe Now